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Short Communication

Effective use of probiotic-glyconutrient combination as an adjuvant to antibiotic therapy
for diarrhea in rearing dairy calves
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Abstract: Thirty Holstein calves presented with infectious diarrhea during the second week following birth were utilized to evaluate the
effects of a standardized product containing a combination of probiotics, β-glucans, and glyconutrients (GLY) in support of antibiotic
therapy during the early rearing phase (day 7 to day 45 following birth). Treatments were 1) antibiotic therapy (trimethoprim and
sulfas; ANTIB), and 2) ANTIB plus 5 g/calf per day GLY. Treatments did not affect diarrhea duration, averaging 16.7 days. However,
GLY support decreased (P < 0.05) the mortality rate and increased (P < 0.05) live weight gain. Increased weight gain was attributable to
enhanced (P < 0.05) consumption of calf starter. Supplemental GLY increased (P < 0.05) serum glucose and lowered (P < 0.05) serum
urea nitrogen, nonesterified fatty acids, and cortisol concentration. We conclude that daily provision of 5 g of a standardized product
containing probiotics, β-glucans, and glyconutrients to diarrheic calves under antibiotic therapy will promote health and enhance early
growth performance.
Key words: Feed additives, diarrhea, dairy calves, glyconutrients, probiotics

The high mortality rate of Holstein calves during the
rearing period is a major concern. Infectious diarrhea
accounts for 70% of this mortality (1). Successful antibiotic
interventions for calves with infectious diarrhea are strongly
associated with the physiological and immunological
capacity of the affected calf (2). Recently, probiotics are
being used as a prophylactic management in rearing calves
with positive results on growth and health status (3).
Beneficial effects are attributed to facilitated maintenance of
intestinal epithelial integrity (4). The use of glyconutrients
in combination with β-glucans and probiotics (GLY)
is popularized in dietary supplements for humans and
some nonruminant species (5). Although not without
controversy (6), the increased use of these substances is
attributed to enhanced cell signaling, promoting general
immune responses, mediating inflammatory responses,
and generalized reduction in cellular stress (5). To the best
of our knowledge, no information is currently available
regarding effects of combining GLY with conventional
antibiotic therapy protocols as a supportive treatment
for young calves diagnosed with infectious diarrhea.
* Correspondence: aplas_99@yahoo.com
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Therefore, an experiment was performed to evaluate the
effects (mortality, days of diarrhea, change in body weight,
and hematological profiles) of a standardized product
containing probiotics, β-glucans, and glyconutrients in
support of antibiotic therapy for calves diagnosed with
infectious diarrhea in a commercial setting.
The experiment was conducted at a commercial dairy
located in the Mexicali valley, Baja California, 34 km south
of the city of Mexicali in northwestern Mexico (32°40ʹ7ʺN;
115°28ʹ6ʺW, about 10 m above sea level, and under
Sonoran desert conditions (BWh classification according
to Köppen). All animal management procedures were
conducted within the guidelines of locally approved
techniques for animal use and care. The inclusion criteria
for the calves used in the experiment were 1) total serum
protein 72 h following birth was adequate (>5.5 g/dL),
and 2) calves had symptoms of infectious diarrhea during
the second week following birth. Of these, 30 Holstein
calves were randomly assigned to two treatment groups
(15 calves/treatment) consisting of either a conventional
antibiotic therapy protocol (ANTIB) or ANTIB plus
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5 g/day of Glycozyme (Maxcell Global Co. Ltd, Seoul,
South Korea), consisting of a standardized mixture of
glyconutrients, β-glucan, probiotics, and enzymes (ANTIB
+ GLY). The daily dose of Glycozyme was weighed using
a precision scale (Ohaus, AS612 mod, Pine Brook, NJ,
USA) and administered combined with milk replacer at
the morning feeding. Following detection of diarrhea,
the ANTIB protocol consisted of 3 daily intramuscular
applications of sulfa/trimethoprim (10 mg sulfas/kg + 2
mg trimethoprim/kg live weight; Sulfa-Jet, Laboratories
Norvet, Torreón, Mexico). If the diarrhea did not subside
within 72 h of therapy, the calves were administered
enrofloxacin intramuscularly (2.5 mg/kg body weight per
day; Floxi-Jet 5%, Laboratories Norvet, Torreón, Mexico)
until recovery. In addition to antibiotics, all calves were
provided with oral electrolytes (1 L/day; Electrodex Calves,
Pisa Agropecuaria, Mexico) along with an antispasmodic
containing prifinium bromide (Prifinial, Vetoquinol de
México, Mexico City). In the case of death, the calves were
necropsied and samples of abnormal tissues of intestines
were taken, cooled (in an ice chest), and immediately sent
to the laboratory for histologic analysis. In the calves that
survived feed intake and changes in body weight were
registered from birth to day 45 of age. All calves included
in the study underwent routine procedures of newborn
calf management, including 4 L colostrum ingestion (2 L
shortly after birth followed by 2 L 6 to 8 h following birth),
and 4 L/day transition milk during the first 7 days. From day
8 through day 45, calves were fed twice daily a commercial
milk replacer (4 L/day; Nodricina-200, Agriband Purina
de México, Mexicali, Mexico), and allowed ad libitum
access to a commercial calf starter (AMPLI-Calf starter
22, Purina Animal Nutrition, LLC, USA) and fresh water.
The calf starter was formulated to meet or exceed the
requirements for calves during the period of the study (7).
The calves were housed in individual pens (100 cm wide,
150 cm long, and 50 cm high) in an indoor facility, with
individual waterers and feed bunks. The calves were daily
monitored from 0600 to 1400. Diarrhea was identified
through the quality of feces deposited on the floor or those
attached to the perianal area of the calf. Only cases of
diarrhea diagnosed by a staff veterinarian as infectious were
included. At birth, all calves were individually weighed
(electronic scale, Salter Breknell, Fairmont, MN, USA).
Approximately 72 h following birth (1000 hours), blood
samples (10 mL) were obtained via the jugular (Venojet,
Terumo Europe, Belgium). Once the clot retraction was
present, the samples were centrifuged (Eppendorf, model
5804 R) for 10 min at 1300 × g at 5 °C. Total protein
concentration was assayed on freshly extracted serum
using a refractometer (Mark Atago, model SPR-N). The
remaining serum was stored at −20 °C until subsequent
determination of glucose, urea N (BUN), nonesterified

fatty acids (NEFA), and cortisol concentrations. Upon
completion of the study (day 45), surviving calves were
individually weighed and blood sampled approximately at
1000 hours. Glucose was determined (spectrophotometric
method; UV-2100, Shimadzu, Kyoto, Japan) using a
diagnostic kit (Sigma-Aldrich, USA). Serum insulin
(Cisbo Assays, USA) and cortisol (MP-Biomedicals, USA)
concentration were determined via RIA. Readings for
the cortisol samples were performed at 450 nm (MPR4,
PerkinElmer Inc., Life Sciences, Germany). Serum NEFAs
were determined according to Abeni et al. (8). Individual
feed delivery and feed refusals were measured daily. Dry
matter was determined by oven drying [method 930.15
(9)]. The trial was analyzed as a completely randomized
design using the MIXED procedure of SAS software
(10). The treatment means were separated using the least
significant difference test (Tukey’s test). Treatment effects
were considered significant when the value of P ≤ 0.05,
and were identified as trends when the value of P > 0.05
and ≤0.10.
Treatment effects on mortality, and body weight
change and diarrhea duration of surviving calves are
shown in Table 1. All cases of diarrhea were confirmed
as cryptosporidiosis by microscopically examination of
stool samples using acid-fast staining and were confirmed
by histopathological findings in the necropsied calves.
There was no treatment effect on duration of diarrhea
in surviving calves, averaging 16.7 days. However, the
supporting antibiotic protocol with GLY reduced calf
mortality (43%, P < 0.05), and increased (59%, P < 0.05)
weight gain of the surviving calves. The increased weight
gain was associated with enhanced starter consumption
(44%, P < 0.05). Although health and productivity
advantages have been demonstrated when probiotics are
used as a prophylactic measure in rearing calves (3,11),
there is limited information of probiotics’ effects on growth
performance and health parameters when calf health is
compromised by infectious diarrhea. However, similarly
to our results, scouring calves that received probiotics
(consisting of Lactobacillus plantarum, Enterococcus
faecium, and Clostridium butyricum) showed fewer days of
scouring and higher immune response (greater peripheral
leukocytes and cytokine mRNA expression levels)
compared with the controls (12). The advantages observed
here for GLY supported calves may be due a positive effect
of GLY on cell stability (5).
Treatment effects on blood metabolites are shown
in Table 2. Serum glucose, urea-N, NEFA, and cortisol
concentration were not different among calves at 3 days of
age (prior to presentation of clinical diarrhea). All serum
metabolite values recorded at 3 days of age are within the
normal range for healthy calves, as recorded in previous
trials (13–15). Upon completion of the study (45 days
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Table 1. Treatment effects on mortality and 45-day growth performance and diarrhea duration of surviving calves.
ANTIBa

ANTIB+GLYb

SEM

Significance

Calves
Initial

15

15

Surviving

8

11

Mortality, %

46.7

26.7

Initial

38.89

39.28

1.51

NS

Final

42.85

45.58

1.90

NS

Weight gain, kg

3.96

6.30

0.563

<0.05

Calf starter intake (DM), kg

45.34

81.14

10.92

<0.05

Diarrhea duration, days

15.88

17.45

12.65

NS

<0.05

Live weight, kg

The antibiotic therapy protocol consisted of a daily intramuscular application of sulfa/ trimethoprim (10 mg
sulfas/kg + 2 mg trimethoprim/kg live weight at the time of detecting the problem for up to 72 h. If diarrhea did
not subside within 72 h of therapy, then continued with intramuscular application of enrofloxacin (2.5 mg/kg body
weight/24 h until recovery. Oral electrolytes and antispasmodic containing prifinium bromide were administered
in all cases.
b
Protocol of antibiotic therapy reinforced with daily intake of 5 g of a standardized compound of the combination
of yeasts and sugars/calf per day. Oral electrolytes and antispasmodic containing prifinium bromide were
administered in all cases.
a

Table 2. Effect of treatments on the profile of some serum parameters related to energy balance and stress
in calves at day 3 of age and at day 45 of the experiment.a
ANTIBb

ANTIB+GLYc

SEM

Significance

45

45

Day 3

87.74

92.78

0.38

NS

Day 45

54.30

70.26

0.28

<0.05

Day 3

5.62

6.26

1.16

NS

Day 45

5.78

4.18

0.76

<0.05

Days of test
Glucose, mg/dL

Urea nitrogen, mg/dL

Cortisol, µg/dL
Day 3

1.79

2.06

0.25

NS

Day 45

1.48

0.95

0.15

<0.05

NEFA, mmol/L
Day 3

0.534

0.510

0.06

NS

Day 45

0.267

0.149

0.02

<0.05

Serum profiles reported correspond to calves surviving through day 45.
The antibiotic therapy protocol consisted of a daily intramuscular application of sulfa/ trimethoprim (10 mg
sulfas/kg + 2 mg trimethoprim/kg live weight at the time of detecting the problem for up to 72 h. If diarrhea
did not subside within 72 h of therapy, then continued with intramuscular application of enrofloxacin
(2.5 mg/kg body weight per 24 h until recovery. Oral electrolytes and antispasmodic containing prifinium
bromide were administered in all cases.
c
Protocol of antibiotic therapy reinforced with daily intake of 5 g of a standardized compound of the
combination of yeasts and sugars/calf per day. Oral electrolytes and antispasmodic containing prifinium
bromide were administered in all cases.
a

b
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of age), surviving calves that received ANTIB+GLY had
serum glucose, urea-N, cortisol, and NEFA concentrations
within a normal range recorded for healthy calves 4 to 10
weeks of age (13,14,16). In contrast, surviving calves that
received ANTIB alone had lower serum glucose (29%, P
< 0.05) and greater NEFA (44%, P < 0.05) concentrations.
Serum urea-N was also greater (29%, P < 0.05) in calves
treated solely with ANTIB, although those values were
not outside the normal range (14). High plasma levels of
NEFA accompanied by a lowered glucose concentration
reflect greater mobilization of body lipids mediated by a
negative energy balance and/or sustained stress (17). The
greater levels of urea-N for the ANTIB treatment could
reflect a decreased rate of anabolism. Surviving calves
that received ANTIB+GLY also showed decreased (36%,
P < 0.05) plasma cortisol concentration, resulting in
concentrations approximating that recorded for unstressed
calves (18). This decrease is consistent with differences in

serum glucose and NEFA as well as growth performance,
reflecting a mediation of generalized stress. It is concluded
that the inclusion of GLY along with conventional
antibiotic therapy promotes health and enhances early
growth performance of calves diagnosed with infectious
diarrhea. However, it is important to consider that the
product additionally contains β-glucans, which also
function as activators of the immune system, and the
magnitude of their role in this study is not considered. It is
necessary to continue research that contributes to elucidate
more deeply the role of glyconutrients in the health and
productivity of livestock.
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